View Single Post
Old 12-16-2012, 02:16 PM   #14
Mandamoo
Senior Member
 
Mandamoo's Avatar
 
Join Date: Jul 2011
Location: Melbourne, Australia
Posts: 432
Re: The HER2 group at San Antonio 2012

Lovely to see pictures of you all and hear your reports. :-)


I am wondering what talk of dealing with herceptin resistance their was? I spoke with my surgeon who is just back from San Antonio and he was all talk of Perjeta - especially in heavily pretreated women (though it is not available for us).
Any thoughts?
Amanda
__________________
Amanda xx
40 year old Mum to three gorgeous kids - son 5 and daughters 8 and 11
Wife to my wonderfully supportive husband of 17 years!
22 February 2011 - Diagnosed Early Breast Cancer IDBC Stage2b (ER/PR -ve, Her2+ve +++) - 38 years old
(L) skin sparing mastectomy with tissue expander, axilla clearance (2/14 affected) clear margins.
Fec*3, Taxotere and herceptin*2 - stopped due to secondary diagnosis

June 24 2011 Stage IV - Skin met, axilla node, multiple lung lesions

Bolero3 trial - Navelbine, Hereptin weekly, daily Everolimus/Placebo
February 2012 - July 2012 Tykerb and Xeloda - skin mets resolved, Lungs initially dramatically reduced but growing again
August 2012 (turn 40!) tykerb and herceptin (denied compassionate use of TDM1) while holidaying in Italy!
September 2012 - January 2013 TDM1 as part of the Th3resa trial - lymph nodes resolved, lungs slowly progressing.
January 2013 - herceptin, carboplatin and Perjeta (compassionate access)
April 2013 - Some progression in lungs and lymph nodes - Abraxane, Herceptin and Perjeta
July 2013 - mixed response - dramatic reduction of most lung disease, progression of smaller lung nodules and cervical and hilar nodes - ? Add avastin.
Mandamoo is offline   Reply With Quote